Peapack-Gladstone Financial Corp’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
Peapack-Gladstone Financial Corp's IHE Position: Q2 2026 in Review
Peapack-Gladstone Financial Corp reduced its iShares US Pharmaceuticals ETF (IHE) stake by 2.7% in Q2 2026, selling an estimated $75.5K and leaving 30,321 shares worth $3M. The position accounts for 0.03% of the portfolio, ranked #306.
Peapack-Gladstone Financial Corp first reported a position in IHE in Q3 2022 and has held it in 16 quarters since. The position peaked at $3.16M in Q1 2023. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- Peapack-Gladstone Financial Corp held 30,321 shares of iShares US Pharmaceuticals ETF worth $3M as of Q2 2026.
- Peapack-Gladstone Financial Corp sold 838 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $75.5K.
- iShares US Pharmaceuticals ETF made up 0.03% of Peapack-Gladstone Financial Corp's portfolio in Q2 2026, its #306 holding.
- Peapack-Gladstone Financial Corp first reported a position in iShares US Pharmaceuticals ETF in Q3 2022 and has held it in 16 quarters since.
- Peapack-Gladstone Financial Corp's iShares US Pharmaceuticals ETF position peaked at $3.16M in Q1 2023.
- 209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on Peapack-Gladstone Financial Corp's 13F filing for Q2 2026, filed 14 Aug 2026.